Evaluation of the radicality of surgical treatment of pediatric patients with osteosarcoma of the maxillofacial region in children
Pediatric Hematology/Oncology and Immunopathology · 14.04.2026 · 25 (1) · 139-144
DOI: 10.24287/j.1103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Hematology/Oncology and Immunopathology, online erschienen am 14.04.2026. Verfasst von E. I. Chechev und 6 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Osteosarcoma of the maxillofacial region is an extremely rare variant of osteosarcoma, accounting for no more than 6–9% of all cases. Unlike tumors located in the bones of the extremities, osteosarcoma of the maxillofacial region is characterized by a lower tendency for distant metastasis. Due to the specific location of the primary lesion in the maxillofacial region, namely the proximity to vital structures, radical surgical intervention is associated with a number of difficulties; however, it is a key element of treatment that determines the prognosis of the disease. Materials and methods. The study included patients under the age of 18 years with a verified osteosarcoma of the maxillofacial region, registered between 2012 and 2024 at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of the Ministry of Healthcare of the Russian Federation. Treatment for high-grade osteosarcoma patients was conducted according to the MAP regimen (based on the EURAMOS-1 protocol). Treatment for low-grade osteosarcoma patients was limited to surgical resection of the primary lesion.
Results
The study included 11 patients (6 boys and 5 girls) with a median age of 11 years. Seven tumors (63.6%) were located in the mandible and four tumors in the maxilla (36.4%). A histological examination revealed 9 (81.9%) cases of high-grade osteosarcoma and 2 (18.1%) cases of low-grade osteosarcoma. The stage distribution was as follows: stage IA, 18.1%; stage IIA, 63.6%; stage IIB, 9.0%; stage III, 9.0%. Local surgical control was performed in all the patients: R0 resection was achieved in 9 (81.9%) cases and R1 in 2 (18.1%) cases. The median follow-up was 7 years. The event-free survival was 91% at 1 year and 64% at 3 years and at 5 years. The overall survival was 100% at 1 year, 82% at 3 years, and 73% at 5 years.
Conclusion
The cornerstone of treatment for patients diagnosed with osteosarcoma is radical surgery. In patients, for whom radical resection is not feasible, survival approaches zero.
Zitieren
APA
Chechev, E. I., Vorozhtsov, I. N., Lopatin, A. V., Babaskina, N. V., Konopleva, E. I., Chuyko, Y. M., & Grachev, N. S. (2026). Evaluation of the radicality of surgical treatment of pediatric patients with osteosarcoma of the maxillofacial region in children. Pediatric Hematology/Oncology and Immunopathology, 25(1), 139-144. https://doi.org/10.24287/j.1103
Vancouver
Chechev EI, Vorozhtsov IN, Lopatin AV, Babaskina NV, Konopleva EI, Chuyko YM, et al. Evaluation of the radicality of surgical treatment of pediatric patients with osteosarcoma of the maxillofacial region in children. Pediatric Hematology/Oncology and Immunopathology. 2026;25(1):139-144. doi:10.24287/j.1103
BibTeX
@article{Chechev2026,
author = {Chechev, E. I. and Vorozhtsov, I. N. and Lopatin, A. V. and Babaskina, N. V. and Konopleva, E. I. and Chuyko, Y. M. and Grachev, Nikolay Sergeevich},
title = {Evaluation of the radicality of surgical treatment of pediatric patients with osteosarcoma of the maxillofacial region in children},
journal = {Pediatric Hematology/Oncology and Immunopathology},
year = {2026},
volume = {25},
number = {1},
pages = {139--144},
doi = {10.24287/j.1103}
}
EUVIMED